Want to talk with our Investor Relations team? Get in touch with us. We'd love to hear from you. Investor Relations. David Straube. Head of Investor Relations.
Missing: epzm | Show results with:epzm
Jun 27, 2022 · Ipsen to acquire Epizyme, expanding its portfolio in oncology ; Investors ; Craig Marks. Vice President, Investor Relations. +44 7584 349 193.
People also ask
Who are the shareholders of EPAM Systems Inc?
What is the ownership structure of EPAM?
Where is EPAM headquarters?
What is the revenue of EPAM?
Epizyme, Inc. (EPZM) SPO - NASDAQ ... EPZM. Company Name, Epizyme, Inc. Exchange, NASDAQ ... Investor Relations · Contact · Careers · Advertise ...
Securities registered pursuant to Section 12(g) of the Act: None. Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in ...
Mar 5, 2020 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
Ipsen is a mid-sized global biopharmaceutical company, improving patients' lives through research and innovation in oncology, rare disease and neuroscience.
Eisai Co. Ltd, or Eisai, holds the rights to develop and commercialize tazemetostat in Japan, and Hutchison China MediTech Investment Limited, or HutchMed, ...
Aug 6, 2013 · Investor Relations. News Release Details ... [EPZM] to Ring The NASDAQ Stock Market Closing Bell ... Stock · Stock Quote & Chart · Historic Stock ...
Get the latest Epizyme Inc. (EPZM) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
Epizyme (EPZM) Financial Statements, Cash Flow and Balance Sheet
www.tipranks.com › epzm › financials
Epizyme (EPZM) financials statements overview reports - Epizyme's market cap is currently ―. The company's EPS TTM is -$1.73; its P/E ratio is -0.9, ...